危重患儿急性肾损伤诊断标准的比较:一项多中心队列研究
这项多中心前瞻性观察性队列研究比较了KDIGO、改良KDIGO和pROCK三种AKI定义及四种基线SCr估算方法对AKI发生率和PICU死亡率的影响。不同定义和基线SCr估算方法导致AKI发生率从6.8%到25.7%不等,AKI患者PICU死亡率为19.0%到35.4%。基于Schwartz公式的KDIGO定义AKI发生率最高(25.7%)但死亡率最低(19.0%),而改良KDIGO则为发生率16.3%、死亡率26.1%。作者认为基于Schwartz方法的改良KDIGO定义使AKI与PICU死亡率高度相关,可能是危重患儿AKI诊断的优选方法。
要点
- 不同AKI定义和基线SCr估算方法导致危重患儿AKI发生率从6.8%到25.7%不等,AKI患者PICU死亡率为19.0%到35.4%。
- 基于Schwartz公式的KDIGO定义AKI发生率为25.7%但PICU死亡率为19.0%,改良KDIGO为AKI发生率16.3%、PICU死亡率26.1%。
- 改良KDIGO下不同基线SCr估算方法间AKI分期一致性均强,一致率>90.0%,加权kappa值>0.8,且PICU死亡率随Schwartz分期的升高而增加。
- 使用NormsMax时,KDIGO与改良KDIGO的AKI发生率相同(13.6%),但PICU死亡率在各AKI分期之间无差异。
- pROCK定义下PICU死亡率不随分期升高而增加,校正混杂因素后AKI 3期与死亡率无关。
适用人群与场景
- 危重患儿,收治于PICU(多中心前瞻性观察性队列研究)
诊断标准与关键阈值
- AKI按KDIGO、改良KDIGO和pROCK三种定义进行定义和分期。
- 基线SCr通过Schwartz公式计算,或估计为上正常值(NormsMax)、入院SCr(AdmSCr)和改良AdmSCr。
研究设计与关键结果
- 多中心前瞻性观察性队列研究,比较KDIGO、改良KDIGO和pROCK定义及不同基线SCr估算方法对AKI发生率、严重程度分布和结局的影响。
- 不同AKI定义和基线SCr估算方法导致AKI发生率从6.8%到25.7%不等;所有定义下AKI患者PICU死亡率为19.0%到35.4%。
- 基于Schwartz公式的KDIGO定义:AKI发生率25.7%,PICU死亡率19.0%;改良KDIGO:AKI发生率16.3%,PICU死亡率26.1%。
- 改良KDIGO下,不同基线SCr估算方法间AKI分期一致性均强,一致率>90.0%,加权kappa值>0.8;PICU死亡率随基于Schwartz的分期升高而增加。
- 使用NormsMax时,KDIGO与改良KDIGO的AKI发生率相同(13.6%),但PICU死亡率在各AKI分期之间无差异。
- pROCK定义下,PICU死亡率不随分期升高而增加,校正混杂因素后AKI 3期与死亡率无关。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于Schwartz方法的改良KDIGO定义使AKI与PICU死亡率高度相关,可能是危重患儿AKI诊断的优选方法,并为提高临床医生诊断儿科AKI的能力带来希望。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Substantial interstudy heterogeneity exists in defining acute kidney injury (AKI) and baseline serum creatinine (SCr). This study assessed AKI incidence and its association with pediatric intensive care unit (PICU) mortality under different AKI and baseline SCr definitions to determine the preferable approach for diagnosing pediatric AKI.
METHODS: In this multicenter prospective observational cohort study, AKI was defined and staged according to the Kidney Disease: Improving Global Outcome (KDIGO), modified KDIGO, and pediatric reference change value optimized for AKI (pROCK) definitions. The baseline SCr was calculated based on the Schwartz formula or estimated as the upper normative value (NormsMax), admission SCr (AdmSCr) and modified AdmSCr. The impacts of different AKI definitions and baseline SCr estimation methods on AKI incidence, severity distribution and AKI outcome were evaluated.
RESULTS: Different AKI definitions and baseline SCr estimates led to differences in AKI incidence, from 6.8 to 25.7%; patients with AKI across all definitions had higher PICU mortality ranged from 19.0 to 35.4%. A higher AKI incidence (25.7%) but lower mortality (19.0%) was observed based on the Schwartz according to the KDIGO definition, which however was overcome by modified KDIGO (AKI incidence: 16.3%, PICU mortality: 26.1%). Furthermore, for the modified KDIGO, the consistencies of AKI stages between different baseline SCr estimation methods were all strong with the concordance rates > 90.0% and weighted kappa values > 0.8, and PICU mortality increased pursuant to staging based on the Schwartz. When the NormsMax was used, the KDIGO and modified KDIGO led to an identical AKI incidence (13.6%), but PICU mortality did not differ among AKI stages. For the pROCK, PICU mortality did not increase pursuant to staging and AKI stage 3 was not associated with mortality after adjustment for confounders.
CONCLUSIONS: The AKI incidence and staging vary depending on the definition and baseline SCr estimation method used. The modified KDIGO definition based on the Schwartz method leads AKI to be highly relevant to PICU mortality, suggesting that it may be the preferable approach for diagnosing AKI in critically ill children and provides promise for improving clinicians' ability to diagnose pediatric AKI.
参考来源
- Kuai Y, Li M, Chen J, et al. Comparison of diagnostic criteria for acute kidney injury in critically ill children: a multicenter cohort study. Crit Care. 2022. PMID: 35799300. doi:10.1186/s13054-022-04083-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。